Subjective and Objective Cancer‐Related Cognitive Impairments Among Systemic and Radiation Therapy‐Naïve Female Cancer Patients
Cancer Medicine · 2025
DOI: 10.1002/cam4.70908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Maria-Chidi C Onyedibe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), A Partnershi…. Hauptthemen laut MEDLINE: Breast Neoplasms, Cognitive Dysfunction, Genital Neoplasms, Female. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Cancer‐related cognitive impairment (CRCI) is a frequent and burdensome problem that is still insufficiently understood and managed. We investigated subjective and objective measures of CRCI, as recommended by the International Cancer and Cognition Task Force (ICCTF) in cancer patients prior to systemic or radiation therapy with respect to potential influencing or associated psychosocial, demographic, or lifestyle factors.
Methods
Female patients with breast or gynecological tumors ( n = 239, mean age = 55.5, SD = 11.6) prior to any systemic or radiation therapy completed validated subjective (FACT‐Cog: perceived cognitive impairment [PCI], perceived cognitive ability [PCA], impact on quality of life [IQoL]) and objective measures of CRCI (Trail Making Test [TMT‐A and ‐B], Controlled Oral Word Association Test [COWA], and Hopkins Verbal Learning Test‐Revised [HVLT‐R]). Association with cross‐sectionally assessed age, body mass index, education, smoking, alcohol intake, sleep problems, social support, anxiety, and pain was investigated using multiple linear regression models.
Results
A quarter (25.1%) of patients showed indication for CRCI based on the PCI score. Subjective and objective CRCI measures showed no or only weak correlations, also when adjusting for age and education (partial Spearman correlations with each other, all | r | ≤ 0.21). Anxiety, sleep problems, and pain were significantly associated with low subjective cognitive function (PCI, PCA, and IQoL). Poor objective cognitive values (TMT, COWA, and HVLT‐R) were mainly determined by higher age and lower education.
Conclusions
Cancer‐related cognitive impairment is not solely (chemo‐)therapy‐induced but may be triggered or influenced by anxiety, sleep problems, and pain. Addressing these issues early in the treatment phase could potentially alleviate perceived CRCI. The ICCTF‐recommended neuropsychological tests do not adequately capture this CRCI prior to systemic or radiation therapy, but could serve as complementary tools to monitor cognitive changes over time, independent of psychosocial influences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), A Partnership Between DKFZ and University Medical Center, Heidelberg, Germany.
- Department Performance and Health, TU Dortmund University, Dortmund, Germany.
ORCID-Profile: Martina E Schmidt, Karen Steindorf
Zitieren
APA
Onyedibe, M. C., Schmidt, M. E., Bizer, P., Zimmer, P., & Steindorf, K. (2025). Subjective and Objective Cancer‐Related Cognitive Impairments Among Systemic and Radiation Therapy‐Naïve Female Cancer Patients. Cancer Medicine. https://doi.org/10.1002/cam4.70908
Vancouver
Onyedibe MC, Schmidt ME, Bizer P, Zimmer P, Steindorf K. Subjective and Objective Cancer‐Related Cognitive Impairments Among Systemic and Radiation Therapy‐Naïve Female Cancer Patients. Cancer Medicine. 2025. doi:10.1002/cam4.70908
BibTeX
@article{Onyedibe2025,
author = {Onyedibe, Maria-Chidi C and Schmidt, Martina E and Bizer, Pauline and Zimmer, Philipp and Steindorf, Karen},
title = {Subjective and Objective Cancer‐Related Cognitive Impairments Among Systemic and Radiation Therapy‐Naïve Female Cancer Patients},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70908}
}
EUVIMED